Mutation status of essential thrombocythemia and primary myelofibrosis defines clinical outcomeJulia Asp, Lars Palmqvist, Björn Andréasson et al.|Haematologica|2016Cited by 29
<i>ASXL1</i> mutations, previous vascular complications and age at diagnosis predict survival in 85 WHO‐defined polycythaemia vera patientsBjörn Andréasson, Julia Asp, Carina Wasslavik et al.|British Journal of Haematology|2020Cited by 12
High Density Sphere Culture of Adult Cardiac Cells Increases the Levels of Cardiac and Progenitor Markers and Shows Signs of VasculogenesisKristina Vukušić, Julia Asp|BioMed Research International|2012Cited by 10
Improved <i><scp>MPL</scp></i> mutation screening with multiplex <scp>PCR</scp> and capillary electrophoresisAngela Cheng Pettersson, Julia Asp, Anita Viskari et al.|British Journal of Haematology|2016Cited by 3
The clinical relevance of broad mutational screening of myeloproliferative neoplasms at diagnosisHelna Pettersson, Julia Asp, Björn Andréasson et al.|Frontiers in Oncology|2023Cited by 2